Editor's take

A Melbourne psychiatrist is requiring new patients to consent to the use of AI for note-taking, or seek alternative care. This policy means patients unwilling to have their sessions recorded and processed by artificial intelligence will be turned away, effectively limiting access to this specific practitioner for those who object.

This development highlights the growing tension between technological adoption in healthcare and patient privacy rights. While AI note-taking tools, such as those developed by companies like Suki or Nuance, promise efficiency for clinicians, this psychiatrist's approach forces a binary choice on patients, potentially exacerbating existing access issues in mental healthcare and raising questions about informed consent in a field where trust is paramount.

The implications for other healthcare providers are significant. It will be crucial to observe if similar practices emerge and how regulatory bodies respond. Furthermore, the development of more robust, transparent, and patient-centric AI solutions for healthcare documentation will be a key factor in determining the future integration of such technologies.